Janssen Pharmaceutica N.V., Belgium

Quick facts

Marketed products

• early initiation of treatment with Risperdal Consta
• Risperidone Long acting injectable · Psychiatry/Neurology
  Risperidone blocks dopamine D2 and serotonin 5-HT2A receptors in the brain to reduce psychotic symptoms and stabilize mood.
• routine initiation of treatment with Risperdal Consta

Phase 2 pipeline

• JNJ-64042056

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Janssen Pharmaceutica N.V., Belgium portfolio CI brief
• Janssen Pharmaceutica N.V., Belgium pipeline updates RSS